Log inSign up

Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou
President & CEO

William Chou

Collapse
Mark Forman
Chief Medical Officer
JW
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
Jiwen Zhang
VP, Regulatory Affairs
SA
Samiah Al-Zaidy
VP, Clinical Development
Kathleen Borthwick
VP, Financial Planning & Analysis
EF
Eden Fucci
VP, Manufacturing Operations
TV
Tiffini Voss
VP, Clinical Development
SH
Stuart Henderson
VP, Corporate Development & Investor Relations
Sue Browne
VP, Biology
Steve Krausert
Vice President, Supply Chain & Planning
AP
Anne Marie Pierce
Finance Operations Specialist
Patricia Elsasser
Director Clinical Operations
BL
Bin Lu
Senior Scientist, Gene Therapy Process And Product Development
Sneh Patel
Senior Scientist
Derek Kichula
Senior Director, Engineering & General Manager
Rich Mastropietro
Executive Director, IT
Rose Johnstone
Executive Director, Data Management
Chelsea Difebbo Ortiz
Executive Director, Patient Advocacy
GI
Glen Kerker II
Director, Regulatory Operations

Teams

+10

Leadership Team

13 members

+9

Scientific Research and Development

12 members

GI
+7

Clinical Operations and Quality Assurance

10 members

+3

Finance and Administrative Support

6 members

Similar companies

Kura Oncology

18 followers

Assembly Biosciences

9 followers

Adverum Biotech

8 followers

REVOLUTION Medicines

5 followers

Immunovant

5 followers

Summit Therapeutics

4 followers

Viridian Therapeutics

2 followers

Fortis Life Sciences

1 follower

Vividion Therapeutics

1 follower

Biosynth

1 follower

Ocugen

1 follower

Explore companies